How can we improve prognosis in diabetic patients with end-stage renal disease?

Diabetes Care

Volumn 22, Issue SUPPL. 2, 1999, Pages

  Ritz, Eberhard ^a   Koch, Michael ^b   Fliser, Danilo ^a   Schwenger, Vedat ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Clin Nephrology and Rheumatology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CAUSE OF DEATH; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC FOOT; DIALYSIS; HEALTH CARE QUALITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; PROGNOSIS; SURVIVAL; VASCULAR ACCESS;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PROGNOSIS; QUALITY OF HEALTH CARE; REGISTRIES;

EID: 0033006287     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Renal Data System: USRDS 1996 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1996.
2. Raine AE: Epidemiology, development and treatment of endstage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 36:99-104, 1993
3. Gusmann RA, Stead WW, Robinson RR: Physical activity and employment status of patients on maintenance hemodialysis. N Engl J Med 304:309-313, 1981
4. Passa P: Diabetic nephropathy in the NIDDM patient on the interface between diabetology and nephrology: what do we have to improve? Nephrol Dial Transplant 12:1316-1318, 1997
5. Lippert J, Ritz E, Schwarzbeck A, Schneider P: The rising tide of endstage renal faiulre from diabetic nephropathy type II: an epidemiological analysis. Nephrol Dial Transplant 10:462-467, 1995
6. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167-194, 1996
7. Marcelli D, Spotti D, Conte F, Limido A, Lonati F, Malberti F, Locatelli F: Prognosis of diabetic patients on dialysis: analysis of Lombardy Registry data. Nephrol Dial Transplant 10:1895-1901, 1995
8. Rodriguez JA, Cleries M, Vela E, and the Renal Registry Committee: Diabetic patients on renal replacement therapy: analysis of Catalan registry data. Nephrol Dial Transplant 12:2501-2509, 1997
9. Ritz E, Lippert J, Keller C: Rapider Anstieg der Zahl niereninsuffizienter Typ II Diabetiker (Editorial). Dtsch Med Wschr 121:1247, 1996
10. Raine AEG: Evolution worldwide of the treatment of patients with advanced diabetic nephropathy by renal replacement therapy In The Kidney and Hypertension in Diabetes Mellitus. 3rd ed. Mogensen CE, Ed. Boston, Kluwer Academic, 1996, p. 473-481
11. Zmirou D, Benhamou PY, Cordonnier D, Borgel F, Balducci F, Papoz L, Halmimi S: Diabetes mellitus prevalence among dialysed patients in France (UREMIDLAB study). Nephrol Dial Transplant 7:1092-1097, 1992
12. Koch M, Kutkuhn B, Grabensee B, Ritz E: Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant. 12:2603-2611, 1997
13. Koch M, Thomas B, Tschöpe W, Ritz E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 36:1113-1117, 1993
14. Koch M, Tschöpe W, Ritz E: Ist die Betreuung niereninsuffizienter Diabetiker in der prädialytischen Phase verbesserungsbedürftig? Dtsch Med Wschr 116:1543-1548, 1991
15. Ritz E, Strzelczyk P: Prävention der terminalen Niereninsuffizienz bei Diabetes mellitus - Stand in Deutschland 1996. In Die Forderungen von St. Vincent: Stand 1996 in Deutschland. Berger M, Trautner C, Eds. Mainz, Germany, Kirchheim Verlag, p. 55-64, 1996
16. Tschöpe W, Koch M, Thomas B, Ritz E: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis results of a prospective study: the German Study Group Diabetes and Uremia. Nephron 64:354-358, 1993
17. Ritz E: Why are lipids not predictive of cardiovascular death in the dialysis patient? Miner Electrolyte Metab 22:9-12, 1996
18. Manske CL, Wang Y, Rector T, Wilson RF, White CW: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992
19. Pommer W, Bressel F, Chen F, Molzahn M: There is room for improvement of preterminal care in diabetic patients with endstage renal failure: the epidemiological evidence in Germany. Nephrol Dial Transplant 12:1318-1321, 1997
20. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA 270:1339-1343, 1993
21. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44:617-621, 1993
22. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B: Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 12:1187-1191, 1997
23. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 21:113-118, 1993
24. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Leurent G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
25. Silberberg JS, Racine N, Barre P, Sniderman AD: Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6:1-4, 1990
26. Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S, Traverso GB: Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on longterm antihypertensive therapy. Kidney Int 44:881-886, 1993
27. Ritz E, Amann K: Optimal hemoglobin during treatment with recombinant human erythropoietin. Nephrol Dial Transplant 13 (Suppl. 2):16-22, 1998